Common terms found in H. pylori biopsy results explained
If your endoscopy report mentions H. pylori, gastritis or inflammation, the wording can be difficult to understand. A gastric biopsy report describes what a pathologist sees in small tissue samples taken from the stomach lining.
This guide explains common terms found in H. pylori biopsy results. It can help you prepare questions for your healthcare provider, but it cannot determine what your individual findings mean without your full medical history and clinical assessment.
What is a gastric biopsy?
During an upper endoscopy, a clinician passes a thin, flexible instrument through the mouth to examine the upper digestive tract. They may take small tissue samples, called biopsies, from the stomach lining.
A pathologist examines these samples under a microscope. The report may describe inflammation, identify H. pylori, or note changes in the stomach lining.
Biopsy-based testing can help diagnose H. pylori when endoscopy is clinically indicated. It can also reveal other stomach conditions that may affect follow-up care.
What does H. pylori positive on a biopsy mean?
A report that identifies H. pylori in gastric tissue indicates that the pathologist detected the bacteria in the sampled tissue. The report may use terms such as “organisms identified,” “H. pylori present” or “positive for H. pylori.”
H. pylori can be identified through histological examination, and some endoscopy procedures also include a rapid urease test on biopsy material.
A positive result should be reviewed with the clinician who ordered the endoscopy. They can explain what it means in your case and discuss appropriate care.
What does chronic active gastritis mean?
“Gastritis” refers to inflammation of the stomach lining. In a biopsy report, “chronic” describes inflammation involving longer-term immune cells, while “active” usually refers to the presence of neutrophils, a type of white blood cell associated with active inflammation.
H. pylori-associated gastritis often includes both chronic and active inflammation. Still, the phrase “chronic active gastritis” alone does not prove that H. pylori is present. The report may identify the organism separately, and other causes of gastritis may need consideration.
Ask your clinician how the inflammation described in your report relates to the test results and your symptoms.
What is a rapid urease test?
H. pylori produces an enzyme called urease. A rapid urease test uses a gastric biopsy sample to detect urease activity. If the enzyme is present, it can cause a chemical indicator in the test medium to change colour.
The rapid urease test can provide results faster than histological examination. A negative result does not always rule out infection, especially when bacterial levels are low or recent medicines may have affected detection.
Your clinician may interpret the rapid urease result alongside the biopsy findings and other tests.
What do atrophy and intestinal metaplasia mean?
Some biopsy reports describe changes in the stomach lining beyond inflammation.
Gastric atrophy
Atrophy means that some of the normal glands in the stomach lining have been lost. It can occur in association with chronic gastritis, including gastritis related to H. pylori.
Intestinal metaplasia
Intestinal metaplasia means that some cells in the stomach lining have changed to resemble cells normally found in the intestine. It is considered a gastric premalignant condition, but it is not the same as cancer.
If either term appears in your report, ask your clinician whether the finding requires follow-up, surveillance or additional assessment. The answer depends on the extent and location of the changes and your individual risk factors.
Can a biopsy miss H. pylori?
Yes. A biopsy samples only small areas of the stomach lining, and H. pylori may not be evenly distributed. Detection can also be affected by bacterial density, biopsy location, tissue processing and recent use of PPIs, antibiotics or bismuth.
For this reason, a negative biopsy result should be interpreted in context. If the clinician still suspects H. pylori, they may consider other testing or repeat testing under appropriate conditions.
A negative result does not automatically mean the biopsy was performed incorrectly. It means the organism was not detected in the sample using that method.
What should you ask your healthcare provider?
If your report includes H. pylori or other gastric findings, consider asking:
- Was H. pylori identified directly in the biopsy?
- Did the report describe chronic active gastritis?
- Were atrophy or intestinal metaplasia found?
- Do I need another test to confirm whether H. pylori is present?
- Does my result require treatment or follow-up?
- When should I have a test to confirm the result after treatment, if treatment is prescribed?
Bring the full pathology report to your appointment. The summary wording alone may not include every detail needed to interpret the findings.
Key takeaways
- A gastric biopsy is a small tissue sample examined by a pathologist.
- A positive biopsy means H. pylori was detected in the sampled tissue.
- Chronic active gastritis describes a pattern of inflammation, but the term alone does not confirm H. pylori.
- Atrophy and intestinal metaplasia are distinct changes in the stomach lining that may need clinical follow-up.
- A negative biopsy may not completely exclude infection, depending on sampling and other factors.
- Your healthcare provider should interpret the full report and explain whether further testing or care is needed.
Biopsy reports use technical terms to describe what the pathologist sees. Understanding those terms can help you have a clearer conversation with your healthcare provider, but the report should always be interpreted alongside your symptoms, medical history and other test results.
This content is provided for educational and informational purposes only. It is not intended as medical advice or a substitute for consultation with a qualified healthcare provider. Always seek the advice of your doctor or other qualified health professional with any questions you may have regarding a medical condition.
References
- World Gastroenterology Organisation. Helicobacter pylori: Global Guideline.
https://www.worldgastroenterology.org/guidelines/helicobacter-pylori/helicobacter-pylori-english - Schuetz AN, Theel ES, et al. Testing for Helicobacter pylori in an era of antimicrobial resistance. Journal of Clinical Microbiology. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10865822/ - American College of Gastroenterology. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024).
https://pubmed.ncbi.nlm.nih.gov/39626064/ - Infectious Diseases Society of America and American Society for Microbiology. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update.
https://doi.org/10.1093/cid/ciae104